MR 7700 Multinuclear Application Clinical Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPhilips Clinical & Medical Affairs Global
About this trial
The purpose of this clinical study is to perform phosphorus nucleus (31P) and sodium nucleus (23Na) imaging of the liver in patients with primary hepatocellular carcinoma (HCC) and healthy volunteers using the MR 7700 Magnetic Resonance Equipment, in order to explore the manifestations of multinuclear imaging in HCC patients and healthy volunteers.
Eligibility criteria
Qualifiers
1. HCC patient group
Age ≥ 18 years;
With clear consciousness, ability to cooperate, and autonomous behavior;
Voluntary agreement to participate in this clinical trial and signing of the subject's informed consent form;
Disqualifiers
HCC patient group and healthy control group
Patients with claustrophobia.
Subject's body temperature > 39.5°C on the day of scanning.
Females who plan to be pregnant within 6 months, and pregnant and lactating females.
Trial design
Treatments tested in this trial
- MR Scanning with Phosphorus nucleus + Sodium nucleus
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov